By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lab21 has licensed worldwide rights to a suite of patents from Cooperative Diagnostics covering real-time PCR technology that the firm will incorporate into molecular diagnostic kits.

The Cambridge, UK-based diagnostic products and services firm said that as part of the agreement it has exclusive use of the technology on a set of biomarker targets for the oncology and infectious disease areas. Financial and other terms of the pact were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.